Anzeige
Mehr »
Login
Samstag, 17.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Breaking News! Taat Lifestyle meldet riesige Kauforder!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrLilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US
FrCureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
FrAlexion and NICE agree confidential discount for Ultomiris use on the NHS
FrNovartis' MS therapy Kesimpta reduces risk of disability progression regardless of relapses
FrVirtually, the same: Is it time to rethink congress strategy?
DoMerck & Co halts development of potential COVID-19 drug MK-7110
DoMaking social sexy
DoMcCann Health UK appoints Jonathan Kukathasan as president
DoIndigo Medical joins imc group
DoGSK discontinues two feladilimab trials in head and neck cancer
DoEuropean Commission approves Opdivo plus Cambometyx for advanced kidney cancer
DoNovartis agrees to help produce Roche's repurposed COVID-19 drug
DoUPDATE: US pauses rollout of J&J's COVID-19 vaccine amid reports of rare blood clots
DoFrom if to how: when imagination and regulation work together
MiBeiGene, Novartis's PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC
MiSaturnino Izquierdo takes on expanded role at McCann Health
MiJ&J delays EU COVID-19 vaccine rollout following pause in the US
MiModerna's booster vaccine for South African variant demonstrates promising early results
MiUK trial evaluating mixed-vaccine regimens includes two more jabs
MiFollow the user - democratising medical conference design
DiUS pauses rollout of J&J's COVID-19 vaccine amid reports of rare blood clots
DiLilly's RET inhibitor Retevmo shows early promise in new cancer types
DiOxford study finds standard asthma medication improves recovery time in COVID-19 patients
DiFDA approves new self-injection administration for Xolair
DiScientific meetings: leveraging on-site, virtual, on-demand and enduring materials